To Know Where You’re Going, Look at Where You’ve Been

Deborah L. Feinstein

A chapter in Healthcare Antitrust, Settlements, and the Federal Trade Commission, 2018, vol. 28, pp 1-24 from Emerald Group Publishing Limited

Abstract: The Federal Trade Commission (FTC) has initiated policies and legal challenges that have shaped the evolution of competition in healthcare. This chapter discusses not only discusses the current matters in healthcare competition, but it also gives a history of past issues faced by the FTC and the approaches used to resolve them. These FTC actions range from challenges to hospital mergers to preventing “reverse payments” from patent holders to generic entrants in pharmaceuticals. Ultimately the healthcare industry faces many unique regulatory and competitive aspects that, while challenging, do not require special rules.

Keywords: Federal Trade Commission; healthcare antitrust; mergers; competition in pharmaceuticals; antitrust litigation; Noerr-Pennington doctrine; L4; K21 (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.emerald.com/insight/content/doi/10.110 ... d&utm_campaign=repec (text/html)
https://www.emerald.com/insight/content/doi/10.110 ... 3-589520180000028001
https://www.emerald.com/insight/content/doi/10.110 ... d&utm_campaign=repec (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eme:rlwezz:s0193-589520180000028001

DOI: 10.1108/S0193-589520180000028001

Access Statistics for this chapter

More chapters in Research in Law and Economics from Emerald Group Publishing Limited
Bibliographic data for series maintained by Emerald Support ().